Sarcopenia Affects Dose in Reinduction Therapy for Metastatic Colorectal Cancer
Sarcopenia is significantly associated with dose reductions but not with dose-limiting toxicities at initiation of CAPOX-B reinduction therapy in patients with mCRC, researchers reported at ESMO 2017 Congress.